Replies to post #793950 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

So — zero or hero. Nothing in between.

You may be right,

But I am not really thrilled about being a hero who goes through torture to win the girl.

So I would rather just eat popcorn and drink a cold beer. :-)

[learningcurve2020]

You ignore the PPHM turned CDMO case I laid out for you multiple times.

[AllSheWrote]

To clarify Happy's point, I think it may be a binary situation, but the company is actively stalling that binary conclusion as long as possible. The company submitted an invalid application to MHRA, waited for the inevitable RFIs which they are unable to answer satisfactorily, and now they are doing nothing. They can just sit idle and do nothing at all except keep issuing new shares to pay the bills (and, more importantly, themselves). They have already said they are not going to tell shareholders anything, so they can maintain the ruse that they are still "engaged" with MHRA when the truth is that they are not really doing anything. There's nothing they can do. They can't magically make scientifically invalid trial results suddenly become valid. The application has not been flat-out denied, so there is nothing material to report. They can just sit, and sit, and sit. And that's exactly what they are doing. Eventually, once MHRA gives them an ultimatum, they will withdraw the application. Hard to say whether they would bother informing shareholders even at that point, but knowing this company I'd say it's less than likely.

[Investor082]

“Only if the MHRA approves DCVax-L and NWBO secures non-dilutive financing (possibly preceding a buyout or speculation about one) will the company survive.”

— Agreed. Both are important. UK approval only without non dilutive financing will still enable the company to survive for a few years. They will continue to trap bag holders as they have been doing for years, but ultimately there will be another 90% drop in the share price and the market cap drops to under well under $100M with all the increase in outstanding shares in 2026 and beyond.

On the other hand, if the UK application is rejected the shares pretty much go under .01 in no time. And then bankruptcy in a few days.

[HappyLibrarian]

Only if the MHRA approves DCVax-L and NWBO secures non-dilutive financing (possibly preceding a buyout or speculation about one) will the company survive.

In the end, it’s all about the money. The “game” you refer to will end the moment the MHRA decides to reject the application.

So — zero or hero. Nothing in between.

No it could be 1. Zero 2. Hero or 3. Meh

Your premise assumes that MHRA approval will result in NWBO abandoning their strategy of silence and exploiting the event for all it’s worth and also bringing that cascade of news that has often been discussed here but never realized.

Again NWBO can have a 3rd Way even if we get approval.

This would be similar to the 3rd way they had after TLD approval when supposedly the excise of the need to protect the integrity of the trial going away would finally cause them to change. It didn’t.

Thus we could get MHRA approval but management and their apologists will move their goalposts for transforming communication and finally making a real effort in the SP to NICE reimbursement approval or even FDA approval.